Comparative Study: Local Consolidation Therapy versus Observation for Oligometastatic Non Small Cell Lung Cancer Patients: Phase II Randomized Trial

We conducted phase II randomized study to determine whether oligometastatic NSCLC without disease progression after first line chemotherapy, have pro-longed progression free survival when treated with local consolidation therapy of residual disease followed by surveillance compared with no local consolidation

Read More